Clinical Trials
13 trialsNCT05582850 2026-05-12
EPRAD
Domain Therapeutics SA
Phase 1 Terminated
NCT07159828 2026-05-06
A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors
Instil Bio
Phase 1 Terminated
NCT06391918 2026-03-13
Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors
GenVivo, Inc.
Phase 1 Terminated
NCT05381909 2026-02-20
A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors
BeOne Medicines
Phase 1 Terminated
NCT05435339 2025-04-22
A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy
Genmab
Phase 1/2 Terminated
NCT05559541 2025-02-19
Study of AK119 Combined With AK104 in Patients With Advanced Solid Tumors
Akeso
Phase 1/2 Terminated
NCT05601219 2025-01-28
A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors
Adanate, Inc
Phase 1 Terminated
NCT06524804 2024-12-18
A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors
Chengdu Baiyu Pharmaceutical Co., Ltd.
Phase 1/2 Terminated
NCT03355066 2024-08-09
A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors
Biosplice Therapeutics, Inc.
Phase 1 Terminated
NCT03209401 2024-02-05
Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies
Georgetown University
Phase 1 Terminated
NCT03892018 2023-05-22
The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol
Athenex, Inc.
Phase 1 Terminated
NCT03992326 2021-03-18
Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors
Centre Hospitalier Universitaire Vaudois
Phase 1 Terminated
NCT03976050 2020-11-18
Phase I Study of HL-085 in Patients With Advanced Solid Tumors
Shanghai Kechow Pharma, Inc.
Phase 1 Terminated